Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Journal of Environmental Pathology, Toxicology and Oncology

 

ISSN for PRINT: 0731-8898

Institutional price:

$672.00

Issues per year:

4

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2006, Volume25

Issue 1-2

  546 pages  

   

click 'Save as...' here to save XML metadata

Issue price - $344.00  

Add to shopping cart

  • New Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy: Chemical Synthesis and Porphyrin Production in In Vitro and In Vivo Biological Systems
  • Aslak Godal
    PhotoCure ASA, Hoffsveien 48, 0377 Oslo, Norway

    Nils O. Nilsen
    Drug Discovery Laboratory AS., Oslo, Norway

    Jo Klaveness
    Drug Discovery Laboratory AS., Oslo, Norway

    Jon Erik Branden
    PhotoCure ASA, Hoffsveien 48, 0377 Oslo, Norway

    Jahn M. Nesland
    Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway

    Qian Peng, PhD
    Pathology Clinic, Rikshospitalet-Radiumhospitalet HF Medical Center, Faculty Division Radiumhospitalet, University of Oslo, Montebello, N-0310 Oslo, Norway


    ABSTRACT

    Photodynamic therapy (PDT) has become a new treatment for several oncological and nononcological disorders. This procedure involves systemic or topical administration of a lesion-localizing photosensitizer or prodrug, followed by irradiation with visible light to cause singlet oxygen-induced damage to the target tissue. 5-aminolevulinic acid (ALA) is an endogenous precursor for several photosensitizing porphyrins formed by heme biosynthesis, and has been studied for PDT with promising results for some superficial diseases of the skin and hollow internal organs. Hydrophilic ALA has a limited ability to penetrate certain biological barriers and has a relatively low selectivity for lesions. In addition, its ability to induce intracellular porphyrins has been shown to be low compared to most esters of ALA. This stimulated a search for lipophilic derivatives of ALA to overcome the shortcomings of ALA. Thirty-two new esters of ALA were prepared and their ability to induce porphyrin formation was assessed in the WiDr human carcinoma cell line in vitro and in the normal skin of Balb/c nude mice in vivo. Branched-chain alkyl esters and substituted benzyl esters were found to be the most efficient porphyrin precursors of the compounds studied.

    Download article, 109-126 pages

    Article price - $35.00  

    Add to shopping cart

    << Previous article   Next article >>

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com